These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration. Twist EC; Mitchell S; Brazell C; Stahl SM; Campbell IC Biochem Pharmacol; 1990 Jan; 39(1):161-6. PubMed ID: 1688704 [TBL] [Abstract][Full Text] [Related]
25. Carcinoid tumors--somatostatine in the diagnosis and therapy. Kinova S; Duris I; Kratochvilova E; Ondrejka P; Payer J Bratisl Lek Listy; 2002; 103(3):108-12. PubMed ID: 12190042 [TBL] [Abstract][Full Text] [Related]
26. [Changes of 5-HT2A receptor binding on platelet of patients with CAD and the effects of exercise test]. Yang L; Lin S; Pang Y; Xu S; Jin L Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Oct; 19(5):337-41. PubMed ID: 10453517 [TBL] [Abstract][Full Text] [Related]
27. Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature. Mao C; el Attar A; Domenico DR; Kim K; Howard JM Int J Pancreatol; 1998 Apr; 23(2):153-64. PubMed ID: 9629513 [TBL] [Abstract][Full Text] [Related]
28. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites. Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973 [TBL] [Abstract][Full Text] [Related]
29. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Feldman JM; O'Dorisio TM Am J Med; 1986 Dec; 81(6B):41-8. PubMed ID: 2432780 [TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Legangneux E; Mora JJ; Spreux-Varoquaux O; Thorin I; Herrou M; Alvado G; Gomeni C Rheumatology (Oxford); 2001 Mar; 40(3):290-6. PubMed ID: 11285376 [TBL] [Abstract][Full Text] [Related]
31. Low plasma tryptophan in carcinoid patients is associated with increased urinary cortisol excretion. Tanke MA; Kema IP; Dijck-Brouwer J; Doornbos B; De Vries EG; Korf J Psychoneuroendocrinology; 2008 Oct; 33(9):1297-301. PubMed ID: 18722719 [TBL] [Abstract][Full Text] [Related]
32. Growth hormone and prolactin secretion in the carcinoid syndrome. Feldman JM; Plonk JW; Bivens CH; Lebovitz HE; Handwerger S Am J Med Sci; 1975; 269(3):333-47. PubMed ID: 125543 [TBL] [Abstract][Full Text] [Related]
33. Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment. Pandey GN; Pandey SC; Ren X; Dwivedi Y; Janicak PG Psychopharmacology (Berl); 2003 Nov; 170(2):115-23. PubMed ID: 12845409 [TBL] [Abstract][Full Text] [Related]
34. L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging. Jager PL; Meijer WG; Kema IP; Willemse PH; Piers DA; de Vries EG J Nucl Med; 2000 Nov; 41(11):1793-800. PubMed ID: 11079485 [TBL] [Abstract][Full Text] [Related]
35. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients. van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693 [TBL] [Abstract][Full Text] [Related]
36. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. Feldman JM Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417 [TBL] [Abstract][Full Text] [Related]
37. [5-HIAA: perspectives in nephrology]. Elghozi JL; Laude D C R Seances Soc Biol Fil; 1989; 183(1):8-25. PubMed ID: 2476203 [TBL] [Abstract][Full Text] [Related]
38. Dieting and weight loss do not affect on the platelet serotonin 5-HT2A receptor. Rahm I; Spigset O; Mjörndal T Eur Neuropsychopharmacol; 2004 Oct; 14(5):381-3. PubMed ID: 15336299 [TBL] [Abstract][Full Text] [Related]
39. Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors. Zuetenhorst JM; Korse CM; Bonfrer JM; Peter E; Lamers CB; Taal BG Clin Chem; 2004 Sep; 50(9):1634-9. PubMed ID: 15247155 [TBL] [Abstract][Full Text] [Related]